Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LSC2 for Limbal Stem Cell Deficiency
NCT03549299Phase 2Unknown
- Sponsor
- RHEACELL
- Start
- Jul 2019
- Primary completion
- Sep 2023
- Modality
- Mesenchymal Stem Cells
- Countries
- 2
01
Overview
A Phase 2 trial of LSC2 in limbal stem cell deficiency (LSCD), sponsored by RHEACELL. Status: unknown.
02
Drugs
LSC2
03
Conditions
limbal stem cell deficiency (LSCD)
Beyond the preview
Go deeper on NCT03549299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03549299.